Acknowledgements
BRUCE
We would like to thank all investigators who contributed to the ACTIVE-J trial, especially the team that conducted CT- and DXA-based HSA. We thank Dr. Tetsuo Nakano for his advice on radiographic assessment; Mr. Shohei Tateishi, Teijin Pharma Ltd., and Ms. Maki Mihoya, while at Teijin Pharma Ltd., for their contribution to data management and statistical analysis; Dr. Yoshiaki Azuma, PhD, Teijin Pharma Ltd., and Dr. Shigeyuki Ishii, PhD, while at Teijin Pharma Ltd., for their comments during the development of the manuscript; and Dr. Bruce Mitlak, MD, Radius Health, Inc., for the careful review and editing of the manuscript. Teijin Pharma Ltd., in conjunction with the Clinical Development Administration Department and outside consultants, developed the study protocol and statistical analysis plan and analyzed the data. Writing support for the development of this manuscript was provided by Archana Patkar, PhD, and Nidhi Kona, MSc, of Cactus Life Sciences (part of Cactus Communications) and funded by Teijin Pharma Ltd.